Slingshot members are tracking this event:
Baxalta Submits Marketing Authorization Application to the European Medicines Agency for ADYNOVI for Treatment of Hemophilia A Patients
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|BXLT||Community voting in process|
Slingshot Insights Explained
Mar 02, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Adynovi, Advate, Recombinant, Hemophilia, Pegylated, Hemophilia A